-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs023328-koopman-final-report-2021.pdf
January 01, 2021 - gynecologic oncologist commented that the tool would be quite useful in monitoring patients in clinical
drug
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017234-wagner-final-report-2011.pdf
January 01, 2011 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017832-dorr-final-report-2012.pdf
January 01, 2012 - specific modules include clinical care guidelines, pertinent lab data/testing, medications/dosages, drug
-
digital.ahrq.gov/sites/default/files/docs/page/understanding_ehrs___common_features_and_strategic_approaches_for_medicaid_schip_6.pdf
January 01, 2007 - partnership in order to use these large observational databases potentially to monitor and identify
adverse drug-related
-
digital.ahrq.gov/sites/default/files/docs/20090121_Practical_Solutions_Transcript.pdf
May 08, 2008 - by exposure of their health data, for
example, who may have been labeled in the pejorative way as drug
-
digital.ahrq.gov/sites/default/files/docs/publication/r36hs021988-hessels-final-report-2013.pdf
January 01, 2013 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017855-friedman-final-report-2013.pdf
January 01, 2013 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical
-
digital.ahrq.gov/sites/default/files/docs/TRANSCRIPT%20OF%20LEVERAGING%20HEALTH%20INFORMATION%20TECHNOLOGY%20FOR%20PATIENT%20EMPOWERMENT_1.pdf
April 08, 2010 - have the medication lists available for the patients online, and
then also to be able to link that to drug
-
digital.ahrq.gov/sites/default/files/docs/page/Research%20Agenda%20for%20Healthcare%20Systems%20Engineering.pdf
February 13, 2007 - One example is software to assess risks of proposed
pharmaceutical prescriptions including drug interactions
-
digital.ahrq.gov/sites/default/files/docs/page/findings-and-lessons-from-improving-management-of-individuals-with-complex-health-care-needs-through-health-it-grant-initiative.pdf
February 20, 2014 - with the aim of increasing appropriate monitoring
for high-risk medications and reducing adverse drug
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs025638-yazdany-final-report-2022.pdf
January 01, 2022 - Rheumatology Informatics System for Effectiveness Patient-Reported Outcome (RISE PRO) Dissemination Project – Final Report
1
Rheumatology Informatics System for Effectiveness Patient-Reported Outcome (RISE-PRO)
Dissemination Project
Principal Investigator:
Jinoos Yazdany, MD, MPH
Co-investi…
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015057-lobach-final-report-2008.pdf
January 01, 2008 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017270-fricton-final-report-2011.pdf
January 01, 2011 - 1. Title Page
E-Health Records to Improve Care for Patients with Chronic Illnesses
A. Principal Investigator: James Fricton, DDS, MS.
Dr. Fricton is a senior research investigator, HealthPartners Research Foundation, Bloomington, Minn., and a
professor, School of Dentistry, University of Minnesota, Minneapolis…
-
digital.ahrq.gov/sites/default/files/docs/page/AHRQ%20NRC%20Evaluation%20Toolkit_0.pdf
September 13, 2012 - Measurement: The number of preventable adverse
drug events is reduced post-implementation. 2) Goal … For
example, you might want to know whether your implementation reduces adverse drug events
(ADEs
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs018831-czaja-final-report-2013.pdf
January 01, 2013 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical
-
digital.ahrq.gov/sites/default/files/docs/citation/k08hs018582-lafleur-final-report-2015.pdf
January 01, 2015 - separately; (3) we only
accepted RCTs that used bisphosphonates at doses approved by the Food and Drug
-
digital.ahrq.gov/sites/default/files/docs/page/SRD_LessonsLearned_0.pdf
October 01, 2010 - The confidentiality of alcohol and drug abuse
patient records from specific treatment facilities receiving
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs018811-krist-final-report-2012.pdf
January 01, 2012 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical
-
digital.ahrq.gov/sites/default/files/docs/page/sustainability-partnerships-and-teamwork-in-health-it-implementation.pdf
December 01, 2012 - Center
Nashan, Georges http://healthit.ahrq.gov/
UC1HS016154Nashanfinalreport2009
Automated Adverse
Drug … Education
Yale University Friedman, Amy L http://healthit.ahrq.gov/
FriedmanR01HS15038
Value of New Drug
-
digital.ahrq.gov/sites/default/files/docs/page/D_ITPrivacyandSecurityPrimer_1.pdf
March 20, 1997 - Food and Drug
Administration, Dept. of Health and Human Services, March 20, 1997.